Open Label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects
Healthy volunteers are administrated single-dose over the period I and II (Crossover) of
Luckyvec 400mg tablet(x 1T) and Glivec 100mg(x 4T)as of Imatinib 400mg.
Every time before and after each medication, PK parameters and safety of Luckyvec 400mg
tablet and Glivec 100mg is performed using a blood sample and conducting some
tests(Laboratory test, V/S, Physical Examination, etc) respectively.
Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
To evaluate the pharmacokinetics of Luckyvec 400mg tablet and Glivec 100mg tablet in healthy subjects
Korea: Food and Drug Administration